Immunitybio is trading 4.2% up at $7.08 on a technical rebound following several weak sessions and a sharp move higher after-hours on July 29.
- The advance appears primarily driven by technical factors and sentiment, as no fresh company-specific news or fundamental catalysts have been identified.
- The stock is also benefiting from a tailwind as major U.S. indices trade higher in early action.